SCHEMBL7411310

SCHEMBL7411310

COc1ccc([N+](=O)[O-])c(C=O)c1O.O=S(=O)(O)c1ccccc1

nearest known ligand 0.49

Known targets — ChEMBL curated mechanism

BTKCACNA1CCACNA1DCACNA1FCACNA1SCACNA2D1CACNA2D2DRD2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQHRH1HTR2AP2RY12

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.45
HPGD P15428 5/20 0.43
ALDH1A1 P00352 5/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 4/20 0.43
S1PR4 O95977 1/20 0.43
S1PR1 P21453 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.43
GFER P55789 1/20 0.43
PAX8 Q06710 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
SIRT1 Q96EB6 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 1/20 0.39
JUN P05412 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4888730 0.87 ERN1 (0.57) ERN1HPGDALDH1A1KMT2AMEN1
SCHEMBL10501311 0.87 ERN1 (0.57) ERN1HPGDALDH1A1KMT2AMEN1
Potassium Ion SCHEMBL10501328 0.86 ERN1 (0.55) ERN1HPGDALDH1A1KMT2AMEN1
SCHEMBL10501123 0.81 ERN1 (0.50) ERN1HPGDALDH1A1KMT2AMEN1
Potassium Ion SCHEMBL10501133 0.80 ERN1 (0.49) ERN1HPGDALDH1A1KMT2AMEN1
SCHEMBL10500645 0.77 ALDH1A1 (0.49) HPGDALDH1A1KMT2AMEN1POLB
SCHEMBL3212120 0.76 ERN1 (0.49) ERN1HPGDALDH1A1KMT2AMEN1
SCHEMBL7408129 0.74 ERN1 (0.71) ERN1HPGDALDH1A1KMT2AMEN1
SCHEMBL3899164 0.73 MAPT (0.49) HPGDKMT2AMEN1POLBMAPT
SCHEMBL10645648 0.72 ALDH1A1 (0.51) HPGDALDH1A1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0220786-B1 SUBSTITUTED QUINAZOLINONES ORTHO PHARMA CORP (US) 1990-11-22 EP disclosed
US-4804756-A Process for preparing 5,6-dialkoxy-4-alkyl-2(1H)-quinazolinones ORTHO PHARMACEUTICAL CORPORATION (US) 1989-02-14 US disclosed
US-4751304-A Process for preparing 5,6-dialkoxy-4-alkyl-2(1H)-quinazolinones ORTHO PHARMACEUTICAL CORPORATION (US) 1988-06-14 US disclosed
EP-0107398-B1 ORTHO SUBSTITUTED DIHYDROXY-2(1H)QUINAZOLINONE-1-ALKANOIC ACIDS ORTHO PHARMA CORP (US) 1988-06-08 EP disclosed
EP-0220786-A2 Substituted quinazolinones ORTHO PHARMACEUTICAL CORPORATION (US) 1987-05-06 EP disclosed
US-4634769-A Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts ORTHO PHARMACEUTICAL CORPORATION (US) 1987-01-06 US disclosed
US-4631283-A RENAL VASODILATORS, CARDIOVASCULAR AGENTS ORTHO PHARMACEUTICAL CORPORATION (US) 1986-12-23 US disclosed
EP-0183348-A1 Process for the preparation of 8-halo-5,6-dialkoxyquinazoline -2,4-diones and their salts ORTHO PHARMACEUTICAL CORPORATION (US) 1986-06-04 EP disclosed
EP-0177256-A2 Process for preparing 5,6-dialkoxy-4-alkyl-2(1h)-quinazolinones ORTHO PHARMACEUTICAL CORPORATION (US) 1986-04-09 EP disclosed
US-4490374-A CARDIOVASCULAR AGENTS ORTHO PHARMACEUTICAL CORPORATION (US) 1984-12-25 US disclosed
EP-0107398-A1 Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids ORTHO PHARMACEUTICAL CORPORATION (US) 1984-05-02 EP disclosed